Literature DB >> 18085374

Kaposi's sarcoma after liver transplantation from a donor with a history of ventriculoperitoneal shunt and craniotomy for primary central nervous system lymphoma: report of a case.

Burak Isik1, Sezai Yilmaz, Vedat Kirimlioglu, Hale Kirimlioglu, Mehmet Yilmaz, Gokhan Sogutlu, Cengiz Ara, Daniel Katz.   

Abstract

The transplantation of organs from donors who have undergone shunt surgery or craniotomy for a malignant central nervous system (CNS) tumor is controversial. We report a case of Kaposi's sarcoma (KS) developing as a result of immunosuppression in the recipient of a liver transplant from a donor who underwent craniotomy and ventriculoperitoneal shunt surgery for primary CNS lymphoma. Polymerase chain reaction assay did not isolate human herpes virus-8 in the Kaposi lesions. To our knowledge, this is the only case ever reported of KS developing after liver transplantation from a donor with lymphoma. Thus, with appropriate screening to exclude possible dissemination, patients with a history of high-grade primary CNS lymphoma treated by ventriculoperitoneal shunt and craniotomy may be accepted as donors.

Entities:  

Mesh:

Year:  2007        PMID: 18085374     DOI: 10.1007/s00595-007-3565-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Questions about the use of organ donors with tumors of the central nervous system.

Authors:  I Penn
Journal:  Transplantation       Date:  2000-07-15       Impact factor: 4.939

Review 2.  Malignant neoplasms associated with human immunodeficiency virus infection.

Authors:  B Safai; B Diaz; J Schwartz
Journal:  CA Cancer J Clin       Date:  1992 Mar-Apr       Impact factor: 508.702

Review 3.  Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients.

Authors:  J L Touraine; J L Garnier; N Lefrancois; J Finaz de Villaine; J M Dubernard; G de Thé; G Lenoir
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 4.  Absence of tumor transmission from a cadaveric renal donor with malignant astrocytoma and a ventriculoperitoneal shunt--two-year recipient follow-up and review of the literature.

Authors:  K Delhey; R Lewis; J Dunn; J Berry; R Gray; C Van Buren; B Kahan
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

5.  Transmission of glioblastoma multiforme through liver transplantation.

Authors:  S Frank; J Müller; C Bonk; G Haroske; H K Schackert; G Schackert
Journal:  Lancet       Date:  1998-07-04       Impact factor: 79.321

6.  Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France.

Authors:  A G Marcelin; N Dupin; P Bossi; V Calvez
Journal:  AIDS       Date:  1998-03-26       Impact factor: 4.177

7.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Transplant tumor registry: donor related malignancies.

Authors:  H Myron Kauffman; Maureen A McBride; Wida S Cherikh; Pamela C Spain; William H Marks; Allan M Roza
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

Review 9.  Sarcomas in organ allograft recipients.

Authors:  I Penn
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

10.  Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

Authors:  Josep M Campistol; Alex Gutierrez-Dalmau; J Vicente Torregrosa
Journal:  Transplantation       Date:  2004-03-15       Impact factor: 4.939

View more
  1 in total

1.  Deceased donor liver transplantation from donors with central nervous system malignancy: Experience of the Inonu University.

Authors:  Volkan Ince; Veysel Ersan; Fatih Ozdemir; Bora Barut; Cemalettin Koc; Burak Isik; Cuneyt Kayaalp; Sezai Yilmaz
Journal:  North Clin Istanb       Date:  2017-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.